AIP
TMO icon

Almanack Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Almanack Investment Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-614
Closed -$302K – 344
2026
Q1 		$302K Buy
614
+9
+1% +$4.88K 0.05% 129
2025
Q4 		$351K Sell
605
-102
-14% -$57.7K 0.06% 121
2025
Q3 		$343K Buy
707
+85
+14% +$39.6K 0.05% 143
2025
Q2 		$252K Hold
622
– – 0.04% 176
2025
Q1 		$310K Sell
622
-32
-5% -$17.3K 0.06% 112
2024
Q4 		$340K Sell
654
-270
-29% -$148K 0.05% 131
2024
Q3 		$572K Buy
924
+43
+5% +$25.5K 0.09% 101
2024
Q2 		$487K Buy
881
+5
+0.6% +$2.86K 0.08% 109
2024
Q1 		$509K Buy
876
+49
+6% +$27.5K 0.09% 102
2023
Q4 		$439K Sell
827
-15
-2% -$7.26K 0.08% 99
2023
Q3 		$426K Sell
842
-10
-1% -$5.33K 0.08% 95
2023
Q2 		$445K Buy
852
+13
+2% +$7.01K 0.08% 99
2023
Q1 		$484K Hold
839
– – 0.1% 89
2022
Q4 		$462K Buy
+839
New +$445K 0.1% 86
2022
Q3 		– Sell
-1,535
Closed -$834K – 931
2022
Q2 		$834K Buy
1,535
+280
+22% +$154K 0.08% 152
2022
Q1 		$742K Sell
1,255
-22
-2% -$12.6K 0.06% 191
2021
Q4 		$852K Buy
1,277
+211
+20% +$132K 0.07% 169
2021
Q3 		$609K Buy
1,066
+196
+23% +$108K 0.05% 220
2021
Q2 		$439K Sell
870
-188
-18% -$88.7K 0.04% 254
2021
Q1 		$483K Sell
1,058
-3
-0.3% -$1.43K 0.05% 243
2020
Q4 		$494K Sell
1,061
-41
-4% -$19.2K 0.06% 209
2020
Q3 		$516K Buy
+1,102
New +$455K 0.06% 201

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Almanack Investment Partners's TMO Position: Q2 2026 in Review

Almanack Investment Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 614 shares — an estimated $302K sold.

Almanack Investment Partners first reported a position in TMO in Q3 2020 and held it in 22 quarters. The position peaked at $852K in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Almanack Investment Partners reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Almanack Investment Partners sold 614 Thermo Fisher Scientific shares in Q2 2026, an estimated $302K.
  • Almanack Investment Partners first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 22 quarters.
  • Almanack Investment Partners's Thermo Fisher Scientific position peaked at $852K in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Almanack Investment Partners's 13F filing for Q2 2026, filed 30 Jul 2026.